BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28720668)

  • 1. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
    Tardito S; Oudin A; Ahmed SU; Fack F; Keunen O; Zheng L; Miletic H; Sakariassen PØ; Weinstock A; Wagner A; Lindsay SL; Hock AK; Barnett SC; Ruppin E; Mørkve SH; Lund-Johansen M; Chalmers AJ; Bjerkvig R; Niclou SP; Gottlieb E
    Nat Cell Biol; 2015 Dec; 17(12):1556-68. PubMed ID: 26595383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
    Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
    Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
    J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.
    Marin-Valencia I; Yang C; Mashimo T; Cho S; Baek H; Yang XL; Rajagopalan KN; Maddie M; Vemireddy V; Zhao Z; Cai L; Good L; Tu BP; Hatanpaa KJ; Mickey BE; Matés JM; Pascual JM; Maher EA; Malloy CR; Deberardinis RJ; Bachoo RM
    Cell Metab; 2012 Jun; 15(6):827-37. PubMed ID: 22682223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.
    Polson ES; Kuchler VB; Abbosh C; Ross EM; Mathew RK; Beard HA; da Silva B; Holding AN; Ballereau S; Chuntharpursat-Bon E; Williams J; Griffiths HBS; Shao H; Patel A; Davies AJ; Droop A; Chumas P; Short SC; Lorger M; Gestwicki JE; Roberts LD; Bon RS; Allison SJ; Zhu S; Markowetz F; Wurdak H
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic therapy: a new paradigm for managing malignant brain cancer.
    Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
    Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin 2A sustains glioblastoma cell dissemination and proliferation.
    Maule F; Bresolin S; Rampazzo E; Boso D; Della Puppa A; Esposito G; Porcù E; Mitola S; Lombardi G; Accordi B; Tumino M; Basso G; Persano L
    Oncotarget; 2016 Aug; 7(34):54632-54649. PubMed ID: 27429043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
    Xu X; Zhang F; Chen X; Ying Q
    Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
    Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
    Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
    Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
    Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
    Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.
    Chinopoulos C; Seyfried TN
    ASN Neuro; 2018; 10():1759091418818261. PubMed ID: 30909720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.